Are statins logical candidates for overcoming limitations of targeting therapies on malignancy : their potential application to gastrointestinal cancers?
It is expected that therapeutic scope of statins will expand considerably in the future as anticancer agents in addition to their proven benefits of hyperlipidemia.
Our finding suggests that miR-214 possibly could be used as a potential prognostic biomarker for triple-negative breast cancer patients.